
Forte Biosciences, Inc.
Forte Biosciences, Inc. (FBRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FBRX · as of Jun 8, 2026
Key Statistics
Explore Forte Biosciences, Inc. Data
fbrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 50.0%
The FBRX analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $65.00, representing +314.81% upside from the current price of $15.67.
Competitors & Peers
fbrx competitorsStock Performance
Full HistoryAbout Forte Biosciences, Inc.
Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tac…
what is forte biosciences, inc. · fbrx stock overview · forte biosciences, inc. company profile · who is forte biosciences, inc. ceo · fbrx NASDAQ · forte biosciences, inc. headquarters · forte biosciences, inc. business segments
About Stock Overview & Key Data
Forte Biosciences, Inc. (FBRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 13, 2017. As of the latest trading session, FBRX stock price is $15.67, with a market capitalization of $217.6M. The stock has returned +31.13% over the past 12 months and -42.54% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Forte Biosciences, Inc. stock is Buy, with an average 12-month price target of $65.00. In fiscal year 2025, Forte Biosciences, Inc. reported revenue of — and net income of -$69.4M. For detailed data — including Forte Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Forte Biosciences, Inc. (FBRX) stock price is $15.67. The stock is traded on NASDAQ under the ticker symbol FBRX. The 52-week range is $9.10 – $35.80.